Marex Group plc

Position in BNTX — BioNTech SE

CIK 1997464 London, X0

Position in BNTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$512,798

+$262,779 QoQ

Shares Held

5,511

+95.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#150

of 282 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Marex Group plc holds $88,179,553 across 55 Biotechnology names. BNTX ranks #19 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TGTX	Tg Therapeutics, Inc.	276,178	$15,173,219
2	SANA	Sana Biotechnology, Inc.	3,989,100	$13,921,959
3	NTLA	Intellia Therapeutics, Inc.	623,600	$10,551,312
4	CRSP	CRISPR Therapeutics AG	170,584	$9,303,650
5	DNLI	Denali Therapeutics Inc.	295,631	$7,603,629
6	MRNA	Moderna, Inc.	88,575	$6,202,907
7	QURE	uniQure N.V.	81,500	$3,753,890
8	ABVX	Abivax S.A.	27,336	$3,642,795

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$512,798	5,511	+95.9%	Shares	Defined	2026-08-14
2026-03-31	$250,019	2,813	-76.0%	Shares	Defined	2026-05-13
2025-12-31	$1,114,887	11,711	+178.1%	Shares	Defined	2026-02-12
2025-09-30	$415,288	4,211	-0.0%	Shares	Defined	2025-11-14
2025-03-31	$383,544	4,212	-1.0%	Shares	Defined	2026-04-02
2024-12-31	$484,743	4,254	-17.8%	Shares	Defined	2026-04-02
2024-09-30	$614,753	5,176	-66.8%	Shares	Defined	2026-04-07
2024-06-30	$1,253,294	15,596	+41.8%	Shares	Defined	2026-04-02
2024-03-31	$1,014,565	10,998	+61.2%	Shares	Defined	2026-04-02
2023-12-31	$720,099	6,823	+4.9%	Shares	Defined	2026-04-02
2023-09-30	$706,811	6,506	-9.5%	Shares	Defined	2026-04-02
2023-06-30	$776,124	7,191	-11.8%	Shares	Defined	2026-04-02
2023-03-31	$1,015,494	8,152	+48.8%	Shares	Defined	2026-04-02
2022-12-31	$823,055	5,479	—	Shares	Defined	2026-04-02
No filing history on record for this holder in this stock.